-
Recipharm Secures Vaccine Manufacturing Deal
contractpharma
January 28, 2022
Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.
-
Construction Works Launch at New Fill Finish Facility in Morocco
contractpharma
January 28, 2022
SENSYO Pharmatech aims to be the largest fill and finish platform in Africa.
-
Ocugen to buy Liminal’s vaccine manufacturing facility in Canada
pharmaceutical-business-review
January 28, 2022
US-based Ocugen has signed a letter of intent (LOI) to acquire Liminal Biosciences’ manufacturing site located in Belleville...
-
Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man
drugs.com
January 27, 2022
In response to claims that a man was denied a heart transplant because he refused to get vaccinated...
-
Biden Administration Withdraws Vaccine Mandate for Large Employers
drugs.com
January 26, 2022
The Biden administration on Tuesday withdrew an emergency COVID-19 vaccine-or-test mandate...
-
Avanti & Croda-Denmark: Advancing Vaccine Adjuvant Research
CPhIonline
January 24, 2022
?In 2020, researchers at Verndari, Inc. investigated a novel microarray skin patch vaccine incorporating subunit glycoprotein antigens and liposomal adjuvants into a trehalose co-formulation.
-
Japan approves Pfizer-BioNTech’s Covid-19 vaccine for children
Pharmaceutical-Technology
January 24, 2022
The vaccine doses that will be administered for children will use one-third of a dose given for adults.
-
Three doses of mRNA COVID vaccines very effective against Omicron and Delta: Study
ExpressPharma
January 24, 2022
The study, from the US Centers for Disease Control and Prevention (CDC), found that boosters of mRNA COVID vaccines are 82 per cent effective in protecting against Omicron variant-associated ED visits.
-
Fourth COVID vaccine partially effective against Omicron: Israeli study
ExpressPharma
January 20, 2022
A fourth dose of COVID-19 vaccine boosts antibodies to higher levels than the third jab but provides only partial protection against the Omicron variant of coronavirus, according to a preliminary study conducted in Israel.
-
Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events
WorldPharmaNews
January 20, 2022
The placebo effect is the well-known phenomenon of a person's physical or mental health improving after taking a treatment with no pharmacological therapeutic benefit - a sugar pill, or a syringe full of saline, for example.